Newly Approved Drug Therapies (410): Anzemet, Hoechst Marion Roussel

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Anzemet

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Hoechst Marion Roussel
Approval Status: Approved February 1998
Treatment for: prevention of nausea and vomiting associated with chemotherapy and surgery

General Information

Anzemet has been approved as an antiemetic that prevents nausea and vomiting associated with chemotherapy and surgery. Anzemet is available in both I.V. and oral formulations.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]